Dopamine agonist monotherapy utilization in patients with Parkinson’s disease

OBJECTIVES: To characterize patients with Parkinson’s disease (PD) who initiated dopamine agonist (DA) monotherapy, describe medication utilization and provider types, and estimate medication adherence and discontinuation rates. METHODS: Retrospective study identified patients with PD in the Optum R...

Descripción completa

Detalles Bibliográficos
Autores principales: Frazer, Monica, Arcona, Steve, Le, Lisa, Sasane, Rahul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842678/
https://www.ncbi.nlm.nih.gov/pubmed/36660109
http://dx.doi.org/10.1016/j.prdoa.2022.100173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842678/
https://www.ncbi.nlm.nih.gov/pubmed/36660109
http://dx.doi.org/10.1016/j.prdoa.2022.100173

Ejemplares similares